Ignite Creation Date:
2024-05-06 @ 3:29 AM
Last Modification Date:
2024-10-26 @ 11:34 AM
Study NCT ID:
NCT02302625
Status:
COMPLETED
Last Update Posted:
2016-03-03
First Post:
2014-11-19
Brief Title:
Cognitive Behavior Therapy for Atopic Dermatitis
Sponsor:
Karolinska Institutet
Organization:
Karolinska Institutet
Study Overview
Official Title:
Exposure-based CBT for Itching in Atopic Dermatitis
Status:
COMPLETED
Status Verified Date:
2016-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Atopic dermatitis is an inflammatory skin disease characterized by itching dry skin and recurrent inflammatory eczema It is one of the most common skin diseases and is associated with reduced quality of life functional impairment and sleep difficulties The present study aims to investigate a new exposure-based cognitive behavioral psychological treatment for the disorder The trial is a small scale open trial n25 with assessments at baseline post-treatment and 6-month follow-up The primary outcome is the SCORAD
Detailed Description:
Atopic dermatitis ADis an inflammatory skin disease characterized by itching dry skin and recurrent inflammatory eczema It is one of the most common skin diseases and is associated with reduced quality of life functional impairment and sleep difficulties There are currently no pharmacological treatments that are effective in curing the disorder in the longer-term Itching is one of the core symptoms in AD and it has been shown that the behavioral response to itching scratching has a maintaining function in AD Reducing scratching may therefore play an important role in alleviating AD Although behavioral aspects play a significant role in AD only a few studies have investigated the effect of psychological treatment for AD These studies have shown promising results and the present study aim to add to the body of knowledge by testing a new form of cognitive behavioral treatment for AD This new treatment is based on the idea that patients could benefit from training in exposure to events that could lead to increase in itching while refraining from scratching To enable this the treatment incorporates more recently developed cognitive behavioral components such as mindfulness training
The present study aims to investigate a new exposure-based cognitive behavioral psychological treatment for the disorder The trial is a small scale open trial n25 with assessments at baseline post-treatment and 6-month follow-up The primary outcome is the SCORAD
The present study aims to investigate a new exposure-based cognitive behavioral psychological treatment for the disorder The trial is a small scale open trial n25 with assessments at baseline post-treatment and 6-month follow-up The primary outcome is the SCORAD
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None